Novartis AG
Naphthyridinedione derivatives
Last updated:
Abstract:
The invention relates to compound of the formula (I') ##STR00001## or a salt thereof, wherein the substituents are as defined in the specification; to its preparation, to its use as medicament and to medicaments comprising it.
Status:
Application
Type:
Utility
Filling date:
10 Oct 2018
Issue date:
15 Aug 2019